327 related articles for article (PubMed ID: 25972510)
21. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
Andersen H; Friis UG; Hansen PB; Svenningsen P; Henriksen JE; Jensen BL
Nephrol Dial Transplant; 2015 May; 30(5):781-9. PubMed ID: 25609736
[TBL] [Abstract][Full Text] [Related]
22. Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
Wang X; Jiang Z; An J; Mao X; Lin F; Sun P
Mol Med Rep; 2018 Mar; 17(3):4273-4280. PubMed ID: 29328476
[TBL] [Abstract][Full Text] [Related]
23. [New insights into the pathophysiology of oedema in nephrotic syndrome].
Rondon-Berrios H
Nefrologia; 2011; 31(2):148-54. PubMed ID: 21461007
[TBL] [Abstract][Full Text] [Related]
24. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis.
Lourdel S; Loffing J; Favre G; Paulais M; Nissant A; Fakitsas P; Créminon C; Féraille E; Verrey F; Teulon J; Doucet A; Deschênes G
J Am Soc Nephrol; 2005 Dec; 16(12):3642-50. PubMed ID: 16267158
[TBL] [Abstract][Full Text] [Related]
25. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy.
Deschênes G; Wittner M; Stefano AD; Jounier S; Doucet A
J Am Soc Nephrol; 2001 Mar; 12(3):598-601. PubMed ID: 11181809
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.
Ji HL; Zhao R; Komissarov AA; Chang Y; Liu Y; Matthay MA
J Biol Chem; 2015 Feb; 290(9):5241-55. PubMed ID: 25555911
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of sodium retention in nephrotic syndrome.
Hinrichs GR; Jensen BL; Svenningsen P
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):207-212. PubMed ID: 31789848
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome.
Besse-Eschmann V; Klisic J; Nief V; Le Hir M; Kaissling B; Ambühl PM
J Am Soc Nephrol; 2002 Sep; 13(9):2199-206. PubMed ID: 12191963
[TBL] [Abstract][Full Text] [Related]
29. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
31. Protease stimulation of renal sodium reabsorption in vivo by activation of the collecting duct epithelial sodium channel (ENaC).
Jacquillet G; Chichger H; Unwin RJ; Shirley DG
Nephrol Dial Transplant; 2013 Apr; 28(4):839-45. PubMed ID: 23222417
[TBL] [Abstract][Full Text] [Related]
32. Urinary plasmin activates collecting duct ENaC current in preeclampsia.
Buhl KB; Friis UG; Svenningsen P; Gulaveerasingam A; Ovesen P; Frederiksen-Møller B; Jespersen B; Bistrup C; Jensen BL
Hypertension; 2012 Nov; 60(5):1346-51. PubMed ID: 22987920
[TBL] [Abstract][Full Text] [Related]
33. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
34. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome.
de Seigneux S; Kim SW; Hemmingsen SC; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F208-17. PubMed ID: 16403831
[TBL] [Abstract][Full Text] [Related]
35. Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
Artunc F; Bohnert BN; Schneider JC; Staudner T; Sure F; Ilyaskin AV; Wörn M; Essigke D; Janessa A; Nielsen NV; Birkenfeld AL; Etscheid M; Haerteis S; Korbmacher C; Kanse SM
Pflugers Arch; 2022 Feb; 474(2):217-229. PubMed ID: 34870751
[TBL] [Abstract][Full Text] [Related]
36. Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency.
Chen Z; Zhao R; Zhao M; Liang X; Bhattarai D; Dhiman R; Shetty S; Idell S; Ji HL
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(8):L609-17. PubMed ID: 25172911
[TBL] [Abstract][Full Text] [Related]
37. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways.
Tencer J; Frick IM; Oquist BW; Alm P; Rippe B
Kidney Int; 1998 Mar; 53(3):709-15. PubMed ID: 9507218
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen Deficiency and Amiloride Mitigate Angiotensin II-Induced Hypertension in Type 1 Diabetic Mice Suggesting Effects Through the Epithelial Sodium Channel.
Andersen H; Hansen MH; Buhl KB; Stæhr M; Friis UG; Enggaard C; Supramaniyam S; Lund IK; Svenningsen P; Hansen PBL; Jensen BL
J Am Heart Assoc; 2020 Dec; 9(23):e016387. PubMed ID: 33215566
[TBL] [Abstract][Full Text] [Related]
40. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
